AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its ...
The adenovirus vector is released with Pac I and then 293 cells are transfected to make the final recombinant adenovirus vector. In the VDL, all adenovirus vectors are produced in compliance with GLP ...